April 17 2018

You are invited to attend an Information Session about SHINGRIX, the new non-live shingles vaccine coming in January 2018.

Shingrix logo

April 17 2018

Location 

The David Duncan House Map
125 Moatfield Dr.
North York, ON
M3B 3L6

Agenda

6:30pm – Registration
7:00pm – Presentation & Dinner
8:00pm – Q&A
8:30pm – Conclusion

Key learning objectives:
• Drug indication
• Mechanism of action
• How SHINGRIX performed in clinical trials
    – Efficacy data
    – Safety profile
    – Adverse events

 

Speaker

Michael Perron, Pharm.D, Ph.D.

Michael Perron has been working in the medical science liaison role with GSK vaccines since May 2017, covering regions in the Greater Toronto Area, Ottawa and Montreal.

Michael has a diverse educational background that includes both research and clinical experience. He first studied at McGill University, completing a B.Sc. in Biochemistry, and then jumped straight into a Ph.D in Pharmacology & Therapeutics, also at McGill.

His research at the Jewish General Hospital in Montreal offered him experience in drug development and immunology. Michael then switched gears into the clinical field at the University of Toronto, where he studied pharmacy and has graduated in 2017 with a Pharm.D. degree.

Along the way, Michael had the opportunity to work in several different pharmacy settings including direct patient care rotations in the cardiology department at North York General Hospital and the stroke rehab clinic at St Joseph’s Health Centre. His first taste of the pharmaceutical industry was in the medical affairs department at Sanofi Pasteur where he worked with vaccines.

Now, Michael supports the vaccines portfolio for GSK as he engages in scientific  discussions with experts in the field.

PRESENTED BY GSK MEDICAL

SHINGRIX is indicated for prevention of herpes zoster (HZ, or shingles) in adults 50 years of age or older. Learn more about SHINGRIX at ThinkSHINGRIX.ca

 

Registration

This Program is now full.  Registration for this program is now closed.  

Register to participate and learn about what SHINGRIX can do to help protect your patients ?50 years of age against shingles.  Seating is limited to 35.  Registration for this program is limited to accredited Pharmacists.  Priority will be given to MTPA Members.  If you are not a member please visit the join page at JOIN MTPA  to ensure a seat.  Please register before April 10 2018

REGISTER HERE